Metastatic adenocarcinoma to the brain: An immunohistochemical approach

Arie Perry, Joseph E Parisi, Paul J. Kurtin

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The diagnosis of metastatic adenocarcinoma to the brain of unknown primary is problematic, and the role of immunohistochemistry in identifying a source has not been fully characterized. Sixty-eight metastatic adenocarcinomas of the brain with known primaries were immunostained with antibodies to cytokeratin 7 (CK7), cytokeratin 20 (CK20), CAM 5.2, wide- spectrum keratin (WSK), gross cystic disease fluid protein-15 (GCDFP-15), glial fibrillary acidic protein (GFAP), estrogen receptor (ER), and progesterone receptor (PR). True positive staining was defined as CK7 in lung or breast; CK20 in gastrointestinal; and GCDFP-15, ER, and PR in breast carcinomas. CK7 immunoreactivity was present in all 27 lung carcinomas and 14 of 15 breast carcinomas with a sensitivity of 98% and specificity of 78%. CK20 stained 15 of 16 GI carcinomas with a sensitivity and specificity of 94%. None of the cytokeratins stained surrounding brain tissue. GCDFP-15, ER, and PR had sensitivities of 33% 33%, and 87%, with specificities of 92%, 84%, and 28%, respectively. PR often stained nuclei of normal brain tissue and was accentuated in areas of necrosis or cautery artifact. CK7 and CK20 are highly sensitive and specific in patients with metastatic adenocarcinoma to the brain of unknown primary. GCDFP-15 and ER are relatively specific, but insensitive markers, and PR is nonspecific and difficult to interpret.

Original languageEnglish (US)
Pages (from-to)938-943
Number of pages6
JournalHuman Pathology
Volume28
Issue number8
DOIs
StatePublished - 1997

Fingerprint

Keratin-20
Keratin-7
Progesterone Receptors
Adenocarcinoma
Brain
Keratins
Breast Neoplasms
Carcinoma
Cautery
Sensitivity and Specificity
Lung
Glial Fibrillary Acidic Protein
Estrogen Receptors
Artifacts
Breast
Necrosis
Immunohistochemistry
Staining and Labeling
Antibodies
estrophilin

Keywords

  • Adenocarcinoma
  • Brain metastases
  • Cytokeratins
  • Immunohistochemistry
  • Tumor of unknown origin

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Metastatic adenocarcinoma to the brain : An immunohistochemical approach. / Perry, Arie; Parisi, Joseph E; Kurtin, Paul J.

In: Human Pathology, Vol. 28, No. 8, 1997, p. 938-943.

Research output: Contribution to journalArticle

Perry, Arie ; Parisi, Joseph E ; Kurtin, Paul J. / Metastatic adenocarcinoma to the brain : An immunohistochemical approach. In: Human Pathology. 1997 ; Vol. 28, No. 8. pp. 938-943.
@article{1640220d448a42d59a39989ded50894c,
title = "Metastatic adenocarcinoma to the brain: An immunohistochemical approach",
abstract = "The diagnosis of metastatic adenocarcinoma to the brain of unknown primary is problematic, and the role of immunohistochemistry in identifying a source has not been fully characterized. Sixty-eight metastatic adenocarcinomas of the brain with known primaries were immunostained with antibodies to cytokeratin 7 (CK7), cytokeratin 20 (CK20), CAM 5.2, wide- spectrum keratin (WSK), gross cystic disease fluid protein-15 (GCDFP-15), glial fibrillary acidic protein (GFAP), estrogen receptor (ER), and progesterone receptor (PR). True positive staining was defined as CK7 in lung or breast; CK20 in gastrointestinal; and GCDFP-15, ER, and PR in breast carcinomas. CK7 immunoreactivity was present in all 27 lung carcinomas and 14 of 15 breast carcinomas with a sensitivity of 98{\%} and specificity of 78{\%}. CK20 stained 15 of 16 GI carcinomas with a sensitivity and specificity of 94{\%}. None of the cytokeratins stained surrounding brain tissue. GCDFP-15, ER, and PR had sensitivities of 33{\%} 33{\%}, and 87{\%}, with specificities of 92{\%}, 84{\%}, and 28{\%}, respectively. PR often stained nuclei of normal brain tissue and was accentuated in areas of necrosis or cautery artifact. CK7 and CK20 are highly sensitive and specific in patients with metastatic adenocarcinoma to the brain of unknown primary. GCDFP-15 and ER are relatively specific, but insensitive markers, and PR is nonspecific and difficult to interpret.",
keywords = "Adenocarcinoma, Brain metastases, Cytokeratins, Immunohistochemistry, Tumor of unknown origin",
author = "Arie Perry and Parisi, {Joseph E} and Kurtin, {Paul J.}",
year = "1997",
doi = "10.1016/S0046-8177(97)90009-5",
language = "English (US)",
volume = "28",
pages = "938--943",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Metastatic adenocarcinoma to the brain

T2 - An immunohistochemical approach

AU - Perry, Arie

AU - Parisi, Joseph E

AU - Kurtin, Paul J.

PY - 1997

Y1 - 1997

N2 - The diagnosis of metastatic adenocarcinoma to the brain of unknown primary is problematic, and the role of immunohistochemistry in identifying a source has not been fully characterized. Sixty-eight metastatic adenocarcinomas of the brain with known primaries were immunostained with antibodies to cytokeratin 7 (CK7), cytokeratin 20 (CK20), CAM 5.2, wide- spectrum keratin (WSK), gross cystic disease fluid protein-15 (GCDFP-15), glial fibrillary acidic protein (GFAP), estrogen receptor (ER), and progesterone receptor (PR). True positive staining was defined as CK7 in lung or breast; CK20 in gastrointestinal; and GCDFP-15, ER, and PR in breast carcinomas. CK7 immunoreactivity was present in all 27 lung carcinomas and 14 of 15 breast carcinomas with a sensitivity of 98% and specificity of 78%. CK20 stained 15 of 16 GI carcinomas with a sensitivity and specificity of 94%. None of the cytokeratins stained surrounding brain tissue. GCDFP-15, ER, and PR had sensitivities of 33% 33%, and 87%, with specificities of 92%, 84%, and 28%, respectively. PR often stained nuclei of normal brain tissue and was accentuated in areas of necrosis or cautery artifact. CK7 and CK20 are highly sensitive and specific in patients with metastatic adenocarcinoma to the brain of unknown primary. GCDFP-15 and ER are relatively specific, but insensitive markers, and PR is nonspecific and difficult to interpret.

AB - The diagnosis of metastatic adenocarcinoma to the brain of unknown primary is problematic, and the role of immunohistochemistry in identifying a source has not been fully characterized. Sixty-eight metastatic adenocarcinomas of the brain with known primaries were immunostained with antibodies to cytokeratin 7 (CK7), cytokeratin 20 (CK20), CAM 5.2, wide- spectrum keratin (WSK), gross cystic disease fluid protein-15 (GCDFP-15), glial fibrillary acidic protein (GFAP), estrogen receptor (ER), and progesterone receptor (PR). True positive staining was defined as CK7 in lung or breast; CK20 in gastrointestinal; and GCDFP-15, ER, and PR in breast carcinomas. CK7 immunoreactivity was present in all 27 lung carcinomas and 14 of 15 breast carcinomas with a sensitivity of 98% and specificity of 78%. CK20 stained 15 of 16 GI carcinomas with a sensitivity and specificity of 94%. None of the cytokeratins stained surrounding brain tissue. GCDFP-15, ER, and PR had sensitivities of 33% 33%, and 87%, with specificities of 92%, 84%, and 28%, respectively. PR often stained nuclei of normal brain tissue and was accentuated in areas of necrosis or cautery artifact. CK7 and CK20 are highly sensitive and specific in patients with metastatic adenocarcinoma to the brain of unknown primary. GCDFP-15 and ER are relatively specific, but insensitive markers, and PR is nonspecific and difficult to interpret.

KW - Adenocarcinoma

KW - Brain metastases

KW - Cytokeratins

KW - Immunohistochemistry

KW - Tumor of unknown origin

UR - http://www.scopus.com/inward/record.url?scp=0030812223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030812223&partnerID=8YFLogxK

U2 - 10.1016/S0046-8177(97)90009-5

DO - 10.1016/S0046-8177(97)90009-5

M3 - Article

C2 - 9269830

AN - SCOPUS:0030812223

VL - 28

SP - 938

EP - 943

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 8

ER -